Murphy S
Department of Social Medicine, University of Bristol, UK.
J Health Serv Res Policy. 1998 Oct;3(4):215-8. doi: 10.1177/135581969800300407.
To determine whether new technology increases or decreases formal health care costs, with reference to the diagnosis and treatment of peptic ulcers.
A costing method has been devised which is designed to investigate directly the way in which the costs to formal health services of diagnosing and treating an individual illness have changed with changes in technology.
The cost of diagnosis has increased almost entirely as a result of the high cost of endoscopy compared with X-ray examination. The introduction of H2-receptor antagonist drugs increased the cost of treatment compared with the earlier phases of surgical treatment. Subsequently, Helicobacter pylori eradication treatment has reduced the cost of treatment compared with all earlier phases of technology.
A method has been devised that allows the impact of changes in medical technology on formal health care costs to be investigated for individual illnesses. In the treatment of peptic ulceration, the current technology, H. pylori eradication, has lower treatment costs than all previous technologies. The evidence from previous studies and this study is insufficient to support the assertion that new technology in general leads either to an increase or to a decrease in health care costs.
参照消化性溃疡的诊断与治疗，确定新技术会增加还是降低正规医疗保健成本。
已设计出一种成本核算方法，旨在直接调查诊断和治疗个体疾病的正规医疗服务成本随技术变化而发生改变的方式。
与X线检查相比，由于内镜检查成本高昂，诊断成本几乎全面增加。与手术治疗的早期阶段相比，H2受体拮抗剂药物的引入增加了治疗成本。随后，与所有早期技术阶段相比，根除幽门螺杆菌治疗降低了治疗成本。
已设计出一种方法，可针对个体疾病研究医疗技术变化对正规医疗保健成本的影响。在消化性溃疡的治疗中，当前的幽门螺杆菌根除技术的治疗成本低于所有先前技术。先前研究和本研究的证据不足以支持新技术总体上会导致医疗保健成本增加或降低这一论断。
